Table 1.

Recent and current clinical trials in pancreatic cancer (further information can be found at www.cancerhelp.org.uk/trials/trials/)

Trial	Phase	Details	Recruitment dates or results
GEM-CAP	III	Single or combination therapy. Comparing gemcitabine alone with a combination of gemcitabine and capecitabine	April 2002 to March 2005
ESPAC 1	III	Compared survival in tumour resected patients having chemoradiotherapy, a combination of chemoradiotherapy and chemotherapy, and no adjuvant treatment	Recently concluded trial showed adjuvant chemotherapy had a significant beneficial effect on survival, whereas chemoradiotherapy had a deleterious effectw13
ESPAC 3 v2	III	Comparing gemcitabine with a combination of fluorouracil and folinic acid	July 2000 to July 2005
MetXia-OB83 and cyclophosphamide	I	Patients will be given a combination of MetXia-OB83 (gene therapy) and cyclophosphamide	March 2004 to October 2005